PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-3.47%
Both yoy net incomes decline, with MRVL at -106.38%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.94%
Less D&A growth vs. MRVL's 3.02%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-30.43%
Negative yoy deferred tax while MRVL stands at 100.31%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.82%
Less SBC growth vs. MRVL's 12.25%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-316.27%
Negative yoy working capital usage while MRVL is 136.67%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-23.27%
AR is negative yoy while MRVL is 721.81%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-328.79%
Both reduce yoy inventory, with MRVL at -17.36%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-31.73%
Negative yoy AP while MRVL is 87.79%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-115.15%
Negative yoy usage while MRVL is 80.73%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-96.83%
Negative yoy while MRVL is 102.72%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-37.95%
Negative yoy CFO while MRVL is 214.53%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-7.64%
Both yoy lines negative, with MRVL at -79.34%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-750.00%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-9533.33%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-50.00%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-43200.00%
We reduce yoy other investing while MRVL is 310.44%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-598.68%
Both yoy lines negative, with MRVL at -103.54%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-152.27%
We cut yoy buybacks while MRVL is 91.60%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.